RDNT — RadNet, Inc.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 790526 ·
Last close
$68.21
Market Cap
$5.37B
52W High
$85.84
52W Low
$50.82
ADV30
725,322
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 622,720,000 | 88,080,000 | 42,551,000 | 7,530,000 | 4,226,351,000 | 726,272,000 | 2,832,300,000 |
| Mar 2026 | 575,631,000 | 25,119,000 | -19,848,000 | -33,466,000 | 3,885,389,000 | 455,339,000 | 2,532,677,000 |
| Dec 2025 | 547,712,000 | 75,931,000 | 35,079,000 | -597,000 | 3,758,563,000 | 767,215,000 | 2,402,677,000 |
| Sep 2025 | 522,869,000 | 72,490,000 | 32,691,000 | 5,417,000 | 3,665,279,000 | 804,716,000 | 2,351,320,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$336,311,000
Investing CF
$-658,087,000
Financing CF
$62,213,000
CapEx
$-234,350,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.68
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-128,903,000
Inventory
—
Receivables
$220,123,000
ST Investments
—
EBIT TTM
$102,547,000
Pretax Income TTM
$32,216,000
Interest Exp TTM
$70,331,000
Analysts
8
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,268,932,096
EBITDA
$276,145,984
Free Cash Flow
$157,737,248
Enterprise Value
$7,696,580,096
Total Cash
$726,272,000
Total Debt
$2,184,037,120
Shares Out
78,697,757
Trailing EPS
$-0.26
Book Value
$13.76
ROE
1.5%
ROA
1.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,040,210,000 | 83,358,000 | -18,652,000 | 3,758,563,000 | 2,402,677,000 | 1,089,890,000 | 298,820,000 |
| Dec 2024 | 1,829,664,000 | 111,277,000 | 2,793,000 | 3,286,690,000 | 2,153,280,000 | 902,308,000 | 233,023,000 |
| Dec 2023 | 1,616,630,000 | 93,000,000 | 3,044,000 | 2,690,473,000 | 1,877,114,000 | 630,695,000 | 220,863,000 |
| Dec 2022 | 1,430,061,000 | 49,838,000 | 10,650,000 | 2,433,907,000 | 1,942,455,000 | 332,995,000 | 146,417,000 |
TTM Snapshot
Revenues TTM
$2,144,442,000
NetIncome TTM
$-14,192,000
OpCashFlow TTM
—
Assets (Latest)
$3,885,389,000
Forward EPS
$0.89
Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $70.00 · spot: $70.91 · call volume: 231 · put volume: 85
Expected Move to 2026-10-16:
±$3.17
(4.48%) —
implied range
$67.74 –
$74.09
· ATM straddle on $70.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SHC | Sotera Health Co | $5.09B | $17.83 | — |
| GRAL | GRAIL, Inc. | $5.92B | $132.61 | — |
| CON | Concentra Group Holdings Parent, Inc. | $4.67B | $36.61 | — |
| OPCH | Option Care Health, Inc. | $4.65B | $31.05 | — |
| LFST | LifeStance Health Group, Inc. | $4.61B | $12.06 | — |
News headlines (Yahoo Finance, 1h cache)
Q2 Testing & Diagnostics Services Earnings: RadNet (NASDAQ:RDNT) Earns Top Marks
2026-10-08 17:44 · Yahoo
New Study Shows DeepHealth AI Could Help Avoid Nearly One in Five Prostate Biopsies
2026-10-08 10:00 · Yahoo
RadNet and WIN-NextGen™ Form a Collaboration to Inspire the Next Generation of Medical Imaging Professionals
2026-10-01 10:00 · Yahoo
1 High-Flying Stock Worth Your Attention and 2 We Ignore
2026-09-18 12:16 · Yahoo
RadNet (RDNT) Stock May Be 23% Below Fair Value On Cash Flow
2026-09-15 02:09 · Yahoo
RadNet to Host Free Prostate Cancer Webinar on September 19, 2026
2026-09-09 10:00 · Yahoo
3 of Wall Street’s Favorite Stocks We Find Risky
2026-09-02 10:44 · Yahoo
RDNT Q2 Earnings & Sales Beat on Advanced Imaging, Guidance Raised
2026-08-11 15:20 · Yahoo
RadNet Inc (RDNT) (Q2 2026) Earnings Call Highlights: Record Revenue and AI-Driven Growth ...
2026-08-10 23:00 · Yahoo
Why DataMEDS’ Acquisition Does Not Seem to Be Very Bullish for MEDS Stock at This Point
2026-09-18 22:11 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.